Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study

• Afisi S. Ismaila,
• Kieran J. Rothnie,
• Robert P. Wood,
• Victoria L. Banks,
• Lucinda J. Camidge,
• Alexandrosz Czira,
• Chris Compton,
• Raj Sharma,
• Shannon N. Millard,
• Olivia Massey,
• David M. G. Halpin

Affiliations

Afisi S. Ismaila

Value Evidence and Outcomes, R&D Global Medical, GSK

Kieran J. Rothnie

Value Evidence and Outcomes, R&D Global Medical, GSK

Robert P. Wood

Real-World Evidence, Adelphi Real World

Victoria L. Banks

Real-World Evidence, Adelphi Real World

Lucinda J. Camidge

Real-World Evidence, Adelphi Real World

Alexandrosz Czira

Value Evidence and Outcomes, R&D Global Medical, GSK

Chris Compton

Global Medical, GSK

Raj Sharma

Global Medical, GSK

Shannon N. Millard

Real-World Evidence, Adelphi Real World

Olivia Massey

Real-World Evidence, Adelphi Real World

David M. G. Halpin

College of Medicine and Health, University of Exeter Medical School, University of Exeter